RhumbLine Advisers’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,480
Closed -$37.5K 4425
2024
Q2
$37.5K Sell
2,480
-11,039
-82% -$167K ﹤0.01% 3757
2024
Q1
$200K Sell
13,519
-432
-3% -$6.38K ﹤0.01% 3178
2023
Q4
$187K Buy
13,951
+72
+0.5% +$965 ﹤0.01% 3221
2023
Q3
$171K Buy
13,879
+1,313
+10% +$16.2K ﹤0.01% 3242
2023
Q2
$155K Buy
+12,566
New +$155K ﹤0.01% 3366
2018
Q2
Sell
-15,121
Closed -$96K 2995
2018
Q1
$96K Sell
15,121
-356
-2% -$2.26K ﹤0.01% 2742
2017
Q4
$125K Sell
15,477
-3,155
-17% -$25.5K ﹤0.01% 2744
2017
Q3
$213K Buy
18,632
+191
+1% +$2.18K ﹤0.01% 2702
2017
Q2
$180K Buy
18,441
+573
+3% +$5.59K ﹤0.01% 2793
2017
Q1
$433K Buy
17,868
+597
+3% +$14.5K ﹤0.01% 2316
2016
Q4
$554K Buy
17,271
+397
+2% +$12.7K ﹤0.01% 2172
2016
Q3
$843K Sell
16,874
-127
-0.7% -$6.35K ﹤0.01% 1914
2016
Q2
$721K Buy
17,001
+2,353
+16% +$99.8K ﹤0.01% 1978
2016
Q1
$965K Buy
14,648
+424
+3% +$27.9K ﹤0.01% 1823
2015
Q4
$884K Buy
14,224
+1,219
+9% +$75.8K ﹤0.01% 1891
2015
Q3
$871K Buy
13,005
+62
+0.5% +$4.15K ﹤0.01% 1855
2015
Q2
$1.26M Buy
12,943
+596
+5% +$58K ﹤0.01% 1719
2015
Q1
$1.15M Buy
12,347
+2,003
+19% +$187K ﹤0.01% 1767
2014
Q4
$920K Buy
10,344
+14
+0.1% +$1.25K ﹤0.01% 1872
2014
Q3
$714K Buy
10,330
+114
+1% +$7.88K ﹤0.01% 1990
2014
Q2
$586K Buy
10,216
+586
+6% +$33.6K ﹤0.01% 2170
2014
Q1
$382K Sell
9,630
-562
-6% -$22.3K ﹤0.01% 2390
2013
Q4
$428K Sell
10,192
-420
-4% -$17.6K ﹤0.01% 2354
2013
Q3
$317K Buy
10,612
+383
+4% +$11.4K ﹤0.01% 2495
2013
Q2
$542K Buy
+10,229
New +$542K ﹤0.01% 2191